• Welcome to SynInnova
  • +1 780 485 2962
  • sales@syninnova.com
  • Welcome Guest
×

Pralsetinib-13Cd3

Our Main Products

Shipping

World wide shipping

24 X 7 service

online service for 24 x 7

Latest Products

Updated Product Catalog

New Products New product

SL-9805 New product

Pralsetinib-13Cd3, >98%

Related CAS No. : [2097132-94-8] of the unlabelled compound

IUPAC Name : (1s,4R)-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-(methoxy-13C-d3)-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)cyclohexane-1-carboxamide

Price And Availability
Pack SizePrice in USDAdd To Shopping CartAvailabilityShipping Status
5MGRequest A Quote
In Stock  Estimated to ship on 20 September 2026
10MGRequest A Quote
In Stock  Estimated to ship on 20 September 2026
25MGRequest A Quote
In Stock  Estimated to ship on 20 September 2026
50MGRequest A Quote
In Stock  Estimated to ship on 20 September 2026
We accept
Chemical Properites
Mol. Formula :
C2613CH29D3FN9O2
Mol. Weight :
537.62
Appearance :
Off-white solid
Melting Point :
Not available
Solubility :
Acetonitrile
For Laboratory research use only, not for drug, household or other uses.

Applications : This is a double labelled version of Pralsetinib, which is a highly potent, selective RET inhibitor for RET driven cancers.

References : Subbiah V. et al.: Cancer Discov., 8(7), 836-849, 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

Recently Viewed Products

Related Products